BJDX · Company research

Bluejay Diagnostics, Inc. Common Stock (BJDX): Stock News & Events

Recent company-linked news records available in the database.

RESEARCH CONTEXT

Understand the numbers

Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.

18records availableHealthcare

Stock News & Events data

Database-backed records only

18 rows
titlesummaryurlsourcepublished atsentimentsentiment scorerelevance score
A cartridge site for a sepsis test is set up ahead of Bluejay's Oct. 23 deadline. - Stock TitanA cartridge site for a sepsis test is set up ahead of Bluejay's Oct. 23 deadline. Stock TitanView source ↗Stock TitanOct 13, 2026neutral00.6
Bluejay Diagnostics (Nasdaq:BJDX) - Stock Analysis - Simply Wall StreetBluejay Diagnostics (Nasdaq:BJDX) - Stock Analysis Simply Wall StreetView source ↗Simply Wall StreetOct 13, 2026neutral00.6
Among 777 patients with sepsis or septic shock, 140 did not survive 28 days in Bluejay's study. - Stock TitanAmong 777 patients with sepsis or septic shock, 140 did not survive 28 days in Bluejay's study. Stock TitanView source ↗Stock TitanOct 6, 2026neutral00.6
$BJDX stock is up 11% today. Here's what we see in our data. - Quiver Quantitative$BJDX stock is up 11% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeAug 28, 2026neutral00.6
Bluejay completes 750-patient study enrollment for Symphony IL-6 - Stock TitanBluejay completes 750-patient study enrollment for Symphony IL-6 Stock TitanView source ↗Stock TitanAug 13, 2026neutral00.6
BJDX Stock Dips As Pivotal Sepsis Trial Hits Key Milestone - timothysykes.comBJDX Stock Dips As Pivotal Sepsis Trial Hits Key Milestone timothysykes.comView source ↗timothysykes.comAug 5, 2026neutral00.6
Bluejay Diagnostics Stock Short Interest Rises to 58.61% | BJDX Stock News - Quiver QuantitativeBluejay Diagnostics Stock Short Interest Rises to 58.61% | BJDX Stock News Quiver QuantitativeView source ↗Quiver QuantitativeAug 3, 2026neutral00.6
BJDX Stock Pulls Back As Traders Watch Key Support - www.timothysykes.comBJDX Stock Pulls Back As Traders Watch Key Support www.timothysykes.comView source ↗www.timothysykes.comJul 14, 2026neutral00.6
BJDX Stock Slides As Traders Study Volatile Chart - www.timothysykes.comBJDX Stock Slides As Traders Study Volatile Chart www.timothysykes.comView source ↗www.timothysykes.comJul 9, 2026neutral00.6
BJDX Stock Pulls Back As Traders Eye Cash Runway - StocksToTradeBJDX Stock Pulls Back As Traders Eye Cash Runway StocksToTradeView source ↗StocksToTradeJul 9, 2026neutral00.6
BJDX Stock Slides As Traders Focus On Cash Runway And Volatility - StocksToTradeBJDX Stock Slides As Traders Focus On Cash Runway And Volatility StocksToTradeView source ↗StocksToTradeJul 7, 2026neutral00.6
$BJDX stock is up 31% today. Here's what we see in our data. - Quiver Quantitative$BJDX stock is up 31% today. Here's what we see in our data. Quiver QuantitativeView source ↗Quiver QuantitativeJul 7, 2026neutral00.6
BJDX Stock Slides As Traders Watch Support Levels - Timothy SykesBJDX Stock Slides As Traders Watch Support Levels Timothy SykesView source ↗Timothy SykesJul 6, 2026neutral00.6
Why Bluejay is turning to U.S. manufacturing for its critical-care tests - Stock TitanWhy Bluejay is turning to U.S. manufacturing for its critical-care tests Stock TitanView source ↗Stock TitanJun 2, 2026neutral00.6
Why Is Bluejay Diagnostics Stock Soaring Tuesday? - BenzingaWhy Is Bluejay Diagnostics Stock Soaring Tuesday? BenzingaView source ↗BenzingaJun 2, 2026neutral00.6
Morning Market Movers: BJDX, DXST, ABTS, SBFM See Big Swings - RTTNewsMorning Market Movers: BJDX, DXST, ABTS, SBFM See Big Swings RTTNewsView source ↗RTTNewsJun 2, 2026neutral00.6
BJDX Stock Rockets On Massive Volume As Traders Pile In - StocksToTradeBJDX Stock Rockets On Massive Volume As Traders Pile In StocksToTradeView source ↗StocksToTradeJun 2, 2026neutral00.6
Bluejay fixes sepsis test production issues, keeps 510(k) plan in view - Stock TitanBluejay fixes sepsis test production issues, keeps 510(k) plan in view Stock TitanView source ↗Stock TitanMay 7, 2026neutral00.6

Informational research only, not financial advice. Forecasts are uncertain and can be wrong.